Pulmozyme

Report
16 Pages
September 2018
Region: Global
Citeline
ID: 4775279

Drug Overview
Developed by Genentech, Pulmozyme is a recombinant form of human deoxyribonuclease I produced by genetically engineered Chinese hamster ovary cells.

In patients with cystic fibrosis, high concentrations of extracellular DNA are commonly found in the sputum as a result of the body’s innate response to respiratory infections.

This increases the viscoelasticity of the mucus, reducing pulmonary function and increasing risk of further infection. Pulmozyme hydrolyzes DNA, reducing the viscoelasticity of sputum and encouraging its clearance.

CONTENTS

OVERVIEW

Drug Overview
Product Profiles
Pulmozyme : Cystic fibrosis

LIST OF FIGURES

Figure 1: Pulmozyme for cystic fibrosis – SWOT analysis
Figure 2: The authors drug assessment summary of Pulmozyme for cystic fibrosis
Figure 3: The authors drug assessment summary of Pulmozyme for cystic fibrosis
Figure 4: Pulmozyme sales for cystic fibrosis across the US and five major EU markets, by country, 2016–25

LIST OF TABLES

Table 1: Pulmozyme drug profile
Table 2: Pulmozyme pivotal trial data in cystic fibrosis
Table 3: Pulmozyme sales for cystic fibrosis across the US and five major EU markets, by country ($m), 2016–25

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€9615EUR$10,000USD£8,249GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€47116EUR$49,000USD£40,419GBP

Table of Contents

Related Topics

Related Reports

PULMOZYME Drug Insight and Market Forecast - 2032

Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024

Idiopathic Pulmonary Fibrosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

Global Cystic Fibrosis Treatment Market Report and Forecast 2023-2031